Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: A 4-Year Perspective

Infection Control and Hospital Epidemiology

Volumn 32, Issue 7, 2011, Pages 673-678

  Cohen, Matan J ^a   Block, Colin ^a   Levin, Phillip D ^a   Schwartz, Carmela ^a   Gross, Ilana ^a   Weiss, Yuval ^a   Moses, Allon E ^a   Benenson, Shmuel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS INFECTION; DISEASE CARRIER; DISEASE SURVEILLANCE; EMERGENCY WARD; EPIDEMIC; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INCIDENCE; INFECTION CONTROL; INTERVENTION STUDY; ISRAEL; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MASS SCREENING; NURSING STAFF; REGRESSION ANALYSIS; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CARRIER STATE; CROSS INFECTION; EPIDEMICS; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; ISRAEL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PATIENT ISOLATION; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 79958763465     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660358     Document Type: Article

References (21)

1. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007;51:3026-3029.
2. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 2008;300:2911-2913.
3. Murray PR, Baron EJ. Manual of Clinical Microbiology. 9th ed. Washington, DC: ASM Press; 2007.
4. Cockerill FR, Wikler MA, Bush K, et al. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update). Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
5. Wikler MA, Cockerill FR, Bush K, et al. Performance standards for antimicrobial disk susceptibility tests: approved standard, 10th ed.Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
6. Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723-2725.
7. Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S, Bishara J. Evaluation of CHROMagar KPC for rapid detection of carbapenem- resistant Enterobacteriaceae. J Clin Microbiol 2008;46: 3110-3111.
8. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006; 50:3098-3101.
9. Shardell M, Harris A, El-Karamy S, Furuno J, Miller R, Perencevich E. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infectious Dis 2007;45:901-907.
10. Harbarth S, Samore M. Interventions to control MRSA: high time for time series analysis? J Antimicrob Chemother 2008;62: 431-433.
11. Wagner A, Soumrai A. Segmented regression analysis of interrupted time series studies in medication use research. J Clinical Pharm Therapeutics 2002;27.
12. Chib S. Estimation and comparison of multiple change-point models. J Econometrics 1998;86:221-241.
13. Murray-Leisure K, Geib S, Graceley D, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-350.
14. Montecalvo M, Jarvis W, Uman J, et al. Infection-control measures reduce transmission of vancomycin resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269-272.
15. Jochimsen E, Fish L, Manning K, et al. Control of vancomycinresistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999;20: 106-109.
16. Sample M, Gravel D, Oxley C, Toye B, Garber G, Ramotar K. An outbreak of vancomycin-resistant enterococci in a hematology- oncology unit: control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002; 23:468-470.
17. Zawacki A, O'Rourke E, Potter-Bynoe G, Macone A, Harbarth S, Goldman D. An outbreak of Pseudomonas aeruginosa and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol 2004;25: 1083-1089.
18. Gregory C, Llata E, Stine N, et al. Outbreak of carbapenemresistant Klebsiella pneumonia in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010;31:476-484.
19. Urban C, Segal-Maurer S, Rahal J. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:1268-1274.
20. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260.
21. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee (HICPAC). 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35:S65-S164.